ArticleJournal of atherosclerosis and thrombosis2018
Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes.
Seigo Sugiyama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
61 papers cite itlatest 60 shown
this paperpooled ittrialcites it